TRPC6 and cardiac hypertrophy: Other researchers also convincingly demonstrated an involvement of TRPC3 and TRPC6 (reviewed in [108]) and transgenic mice expressing dominant-negative forms of TRPC3, TRPC6 and TRPC4, which will also inhibit TRPC1 heteromeric, but not homomeric, channels are almost completely protected from cardiac hypertrophy [111].